drugset / Trial / NCT05841147

Reduction of Microembolism After the Intervention Surgery of Intracranial Aneurysms by Administration of Tirofiban

NCT05841147

Phase 4 Unknown 70 enrolled Lu Hua
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The goal of this clinical trial is to investigate whether intravenous injection of tilofiban can reduce microembolism in patients with unruptured intracranial aneurysms after Stent-Assisted Coil Embolization.The main questions it aims to answer are: * Is it safe to inject tirofiban intravenously during interventional treatment of intracranial aneurysms? * What dose of tirofiban is safe and effective?

Timeline

Start
2023-04-25
Primary completion
2023-07-31
Completion
2023-08-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Tirofiban Other / unclassified 0.1 ug/kg Intravenous

Indications